| 1 | IBD Is Like a Tree: Reflections From Older Adults With Inflammatory Bowel Disease | 2.3 | 6 | Citations (PDF) |
| 2 | Diet and Microbiome-Directed Therapy 2.0 for IBD | 5.0 | 37 | Citations (PDF) |
| 3 | A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease | 2.3 | 9 | Citations (PDF) |
| 4 | Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort | 2.3 | 4 | Citations (PDF) |
| 5 | Outcomes of Long-term Tumor Necrosis Factor Alpha Inhibitor Therapy Beyond 10 Years in Inflammatory Bowel Disease | 5.0 | 2 | Citations (PDF) |
| 6 | A Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression | 2.7 | 3 | Citations (PDF) |
| 7 | Assessment and reporting of extraintestinal manifestations and fatigue in phase 3 inflammatory bowel disease clinical trials | 0.9 | 3 | Citations (PDF) |
| 8 | Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative Colitis | 2.3 | 5 | Citations (PDF) |
| 9 | Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease | 1.8 | 7 | Citations (PDF) |
| 10 | Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities | 58.2 | 212 | Citations (PDF) |
| 11 | A Comprehensive Review of Geriatric Syndromes and Assessment in Older Adults With Inflammatory Bowel Diseases | 5.0 | 12 | Citations (PDF) |
| 12 | Epidemiology, Natural History, and Treatment of Inflammatory Bowel Disease in Africa: A Scoping Review | 5.0 | 11 | Citations (PDF) |
| 13 | Existential Reflections by Older Adults With Inflammatory Bowel Diseases on Medical and Surgical Treatments | 0.7 | 1 | Citations (PDF) |
| 14 | Liver Transplantation Is Associated With a Reduced Risk of Colorectal Dysplasia in Patients With IBD and Concomitant PSC | 5.0 | 5 | Citations (PDF) |
| 15 | ACG Clinical Guideline Update: Ulcerative Colitis in Adults | 0.7 | 173 | Citations (PDF) |
| 16 | Outcomes Associated With Anti‐Depressant Use in Patients With Inflammatory Bowel Disease | 2.7 | 3 | Citations (PDF) |
| 17 | An International Multicenter Study of Native and Immigrant South Asian Crohn’s Disease | 5.0 | 6 | Citations (PDF) |
| 18 | Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel Disease in the United States | 5.0 | 7 | Citations (PDF) |
| 19 | Risk of Cancer Recurrence in Patients With Immune-Mediated Diseases With Use of Immunosuppressive Therapies: An Updated Systematic Review and Meta-Analysis | 5.0 | 35 | Citations (PDF) |
| 20 | Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis | 0.9 | 11 | Citations (PDF) |
| 21 | Precision medicine in inflammatory bowel diseases | 2.3 | 19 | Citations (PDF) |
| 22 | Differential Impact of Smoking on Methylome and Transcriptome in Crohn’s Disease and Ulcerative Colitis | 2.3 | 12 | Citations (PDF) |
| 23 | Pharmacoequity for Older Adults With Inflammatory Bowel Diseases | 5.0 | 1 | Citations (PDF) |
| 24 | Pharmacoequity for Older Adults With Inflammatory Bowel Diseases | 0.9 | 3 | Citations (PDF) |
| 25 | Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases | 1.5 | 14 | Citations (PDF) |
| 26 | Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis | 2.3 | 24 | Citations (PDF) |
| 27 | Meta‐analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease | 2.7 | 16 | Citations (PDF) |
| 28 | Physical Activity is Associated with a Decreased Risk of Developing Inflammatory Bowel Disease: A Systematic Review and Meta-analysis | 0.9 | 24 | Citations (PDF) |
| 29 | Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases | 12.2 | 52 | Citations (PDF) |
| 30 | Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases | 1.5 | 6 | Citations (PDF) |
| 31 | Meta‐analysis: Risk of lymphoma in patients with inflammatory bowel disease in population‐based cohort studies | 2.7 | 10 | Citations (PDF) |
| 32 | Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis | 0.9 | 81 | Citations (PDF) |
| 33 | S1146 Inflammatory Bowel Disease (IBD)-Associated Peripheral Arthritis is Not Associated With Objective Markers of Luminal IBD Disease Activity - Results From the CHASE Cohort | 0.7 | 0 | Citations (PDF) |
| 34 | AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis | 0.9 | 195 | Citations (PDF) |
| 35 | Fecal Calprotectin as a Biomarker for Disease Activity in Microscopic Colitis | 1.6 | 0 | Citations (PDF) |
| 36 | Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020 | 5.0 | 10 | Citations (PDF) |
| 37 | Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF Antagonists | 5.0 | 16 | Citations (PDF) |
| 38 | Inflammatory Bowel Disease Is Associated With Prediagnostic Perturbances in Metabolic Pathways | 0.9 | 38 | Citations (PDF) |
| 39 | Histologic Activity in an Endoscopically Normal-Appearing Pouch Predicts Future Risk of Pouchitis in Patients With Ulcerative Colitis | 0.7 | 8 | Citations (PDF) |
| 40 | Lifestyle factors for the prevention of inflammatory bowel disease | 10.3 | 76 | Citations (PDF) |
| 41 | Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis | 5.0 | 100 | Citations (PDF) |
| 42 | Remodeling of colon plasma cell repertoire within ulcerative colitis patients | 5.9 | 40 | Citations (PDF) |
| 43 | Mild Crohn’s Disease: Definition and Management | 2.2 | 25 | Citations (PDF) |
| 44 | AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis | 0.9 | 156 | Citations (PDF) |
| 45 | Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data | 5.0 | 46 | Citations (PDF) |
| 46 | Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis | 10.3 | 22 | Citations (PDF) |
| 47 | Economic Burden of Fatigue in Inflammatory Bowel Disease | 1.1 | 15 | Citations (PDF) |
| 48 | Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis | 1.3 | 16 | Citations (PDF) |
| 49 | Longitudinal trajectories of anxiety, depression, and bipolar disorder in inflammatory bowel disease: a population-based cohort study | 6.6 | 45 | Citations (PDF) |
| 50 | A Narrative Review of Financial Burden, Distress, and Toxicity of Inflammatory Bowel Diseases in the United States | 0.7 | 37 | Citations (PDF) |
| 51 | Periodontal disease is not associated with risk of inflammatory bowel disease: Results from two prospective cohort studies in the US | 2.7 | 13 | Citations (PDF) |
| 52 | S877 Diagnosis of Inflammatory Bowel Disease Associated Peripheral Arthritis: A Systematic Review | 0.7 | 0 | Citations (PDF) |
| 53 | S937 Dietary Nut and Legume Intake and Risk of Inflammatory Bowel Disease in US Adults | 0.7 | 1 | Citations (PDF) |
| 54 | AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease | 0.9 | 108 | Citations (PDF) |
| 55 | Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With Prior Malignancy: A Retrospective Cohort Study | 5.0 | 48 | Citations (PDF) |
| 56 | Dietary Gluten Intake Is Not Associated With Risk of Inflammatory Bowel Disease in US Adults Without Celiac Disease | 5.0 | 16 | Citations (PDF) |
| 57 | Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis | 5.0 | 7 | Citations (PDF) |
| 58 | Ultra-processed Foods and Risk of Crohn’s Disease and Ulcerative Colitis: A Prospective Cohort Study | 5.0 | 157 | Citations (PDF) |
| 59 | Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults | 5.0 | 43 | Citations (PDF) |
| 60 | Alcohol Consumption is Associated With An Increased Risk of Microscopic Colitis: Results From 2 Prospective US Cohort Studies | 2.3 | 12 | Citations (PDF) |
| 61 | Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: A nested case control analysis in the Nurses’ Health Study cohorts | 5.7 | 25 | Citations (PDF) |
| 62 | Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases | 5.0 | 41 | Citations (PDF) |
| 63 | Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases | 15.0 | 35 | Citations (PDF) |
| 64 | Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype | 5.0 | 17 | Citations (PDF) |
| 65 | Smoking Behaviour Changes After Diagnosis of Inflammatory Bowel Disease and Risk of All-cause Mortality | 0.9 | 4 | Citations (PDF) |
| 66 | Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis | 2.3 | 15 | Citations (PDF) |
| 67 | Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases | 1.5 | 40 | Citations (PDF) |
| 68 | A United States expert consensus to standardise definitions, follow‐up, and treatment targets for extra‐intestinal manifestations in inflammatory bowel disease | 2.7 | 30 | Citations (PDF) |
| 69 | Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts | 2.7 | 19 | Citations (PDF) |
| 70 | Sugars and Gastrointestinal Health | 5.0 | 72 | Citations (PDF) |
| 71 | Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel | 0.7 | 9 | Citations (PDF) |
| 72 | Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus | 15.0 | 143 | Citations (PDF) |
| 73 | E-cigarette Use and Disease Outcomes in Inflammatory Bowel Diseases: A Case-Control Study | 1.5 | 10 | Citations (PDF) |
| 74 | Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment | 33.1 | 541 | Citations (PDF) |
| 75 | Precision medicine: how multiomics will shape the future of inflammatory bowel disease? | 1.6 | 17 | Citations (PDF) |
| 76 | Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases | 0.7 | 28 | Citations (PDF) |
| 77 | Endogenous Levels of Circulating Androgens Are Not Associated with Risk of Microscopic Colitis | 1.5 | 2 | Citations (PDF) |
| 78 | Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study | 1.8 | 9 | Citations (PDF) |
| 79 | Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis | 5.0 | 147 | Citations (PDF) |
| 80 | Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab | 5.0 | 77 | Citations (PDF) |
| 81 | Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis | 5.0 | 19 | Citations (PDF) |
| 82 | Robust and efficient semi‐supervised estimation of average treatment effects with application to electronic health records data | 1.1 | 22 | Citations (PDF) |
| 83 | Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases | 5.0 | 79 | Citations (PDF) |
| 84 | Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases | 5.0 | 63 | Citations (PDF) |
| 85 | Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis | 2.3 | 15 | Citations (PDF) |
| 86 | Characteristics and Long-Term Outcomes of Pregnancy-Onset Inflammatory Bowel Disease: A Case-Control Study | 2.3 | 9 | Citations (PDF) |
| 87 | Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn’s Disease in Endoscopic Remission | 5.0 | 25 | Citations (PDF) |
| 88 | Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials | 5.0 | 46 | Citations (PDF) |
| 89 | AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review | 0.9 | 86 | Citations (PDF) |
| 90 | Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases | 2.3 | 59 | Citations (PDF) |
| 91 | Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance | 2.3 | 37 | Citations (PDF) |
| 92 | Diet in Treatment of Inflammatory Bowel Diseases | 5.0 | 117 | Citations (PDF) |
| 93 | Frailty in inflammatory bowel diseases: an emerging concept | 2.0 | 44 | Citations (PDF) |
| 94 | Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review | 2.0 | 60 | Citations (PDF) |
| 95 | Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD | 1.5 | 72 | Citations (PDF) |
| 96 | Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases | 2.3 | 0 | Citations (PDF) |
| 97 | Nutrition in the Management of Inflammatory Bowel Diseases | 1.6 | 8 | Citations (PDF) |
| 98 | Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases | 2.3 | 45 | Citations (PDF) |
| 99 | Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty | 1.5 | 44 | Citations (PDF) |
| 100 | Therapeutic Drug Monitoring of Non-Anti-Tumor Necrosis Factor Biologics | 5.0 | 9 | Citations (PDF) |
| 101 | High Anti-Infliximab Antibody Titers Do Not Impact Response to Subsequent Adalimumab Treatment in Inflammatory Bowel Diseases | 1.5 | 5 | Citations (PDF) |
| 102 | Plant-Based Diet Quality and Risk of Crohn’s Disease and Ulcerative Colitis in US Women | 0.3 | 2 | Citations (PDF) |
| 103 | Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease | 12.2 | 228 | Citations (PDF) |
| 104 | Efficacy and Safety of Fecal Transplantation Versus Targeted Therapies in Ulcerative Colitis: Network Meta-Analysis | 1.4 | 18 | Citations (PDF) |
| 105 | Immune‐mediated diseases and risk of Crohn’s disease or ulcerative colitis: a prospective cohort study | 2.7 | 26 | Citations (PDF) |
| 106 | Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study | 2.3 | 31 | Citations (PDF) |
| 107 | Women’s Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy | 1.8 | 5 | Citations (PDF) |
| 108 | Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis | 5.0 | 48 | Citations (PDF) |
| 109 | Ulcerative Colitis and Crohn’s Disease Have Similar Burden and Goals for Treatment | 5.0 | 231 | Citations (PDF) |
| 110 | Association Between Vulvovaginal Discomfort and Activity of Inflammatory Bowel Diseases | 5.0 | 23 | Citations (PDF) |
| 111 | Opportunistic Infections Are More Prevalent in Crohn’s Disease and Ulcerative Colitis: A Large Population-Based Study | 2.3 | 32 | Citations (PDF) |
| 112 | Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study | 0.9 | 54 | Citations (PDF) |
| 113 | Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases | 5.0 | 65 | Citations (PDF) |
| 114 | Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission | 2.7 | 71 | Citations (PDF) |
| 115 | Use of Narrative Concepts in Electronic Health Records to Validate Associations Between Genetic Factors and Response to Treatment of Inflammatory Bowel Diseases | 5.0 | 2 | Citations (PDF) |
| 116 | Estimating average treatment effects with a double‐index propensity score | 1.1 | 15 | Citations (PDF) |
| 117 | Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease | 2.3 | 47 | Citations (PDF) |
| 118 | Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases | 5.0 | 25 | Citations (PDF) |
| 119 | Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study | 1.5 | 8 | Citations (PDF) |
| 120 | Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions | 1.1 | 5 | Citations (PDF) |
| 121 | Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States | 1.1 | 10 | Citations (PDF) |
| 122 | Multi-“-Omics” Profiling in Patients With Quiescent Inflammatory Bowel Disease Identifies Biomarkers Predicting Relapse | 2.3 | 52 | Citations (PDF) |
| 123 | Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century | 5.0 | 263 | Citations (PDF) |
| 124 | Dietary Inflammatory Potential and Risk of Crohn’s Disease and Ulcerative Colitis | 0.9 | 161 | Citations (PDF) |
| 125 | Sa1836 FRAILTY AS A RISK FACTOR FOR HOSPITAL READMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE STUDY | 0.9 | 1 | Citations (PDF) |
| 126 | Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools | 26.4 | 1 | Citations (PDF) |
| 127 | Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis | 0.7 | 68 | Citations (PDF) |
| 128 | Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases | 2.7 | 76 | Citations (PDF) |
| 129 | Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study | 1.5 | 12 | Citations (PDF) |
| 130 | Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases | 0.9 | 125 | Citations (PDF) |
| 131 | Management of Inflammatory Bowel Diseases: Clinical Perspectives | 5.0 | 1 | Citations (PDF) |
| 132 | Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases | 5.0 | 281 | Citations (PDF) |
| 133 | Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005–2016) | 5.0 | 36 | Citations (PDF) |
| 134 | Automated ICD coding via unsupervised knowledge integration (UNITE) | 2.6 | 30 | Citations (PDF) |
| 135 | Microbiome-Based Biomarkers for IBD | 2.3 | 40 | Citations (PDF) |
| 136 | A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases | 1.5 | 15 | Citations (PDF) |
| 137 | Impact of Diet on Risk of IBD | 1.1 | 11 | Citations (PDF) |
| 138 | Reply | 5.0 | 0 | Citations (PDF) |
| 139 | Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative ColitisCell, 2019, 178, 714-730.e22 | 23.4 | 1,430 | Citations (PDF) |
| 140 | The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel Diseases | 1.1 | 58 | Citations (PDF) |
| 141 | Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data | 2.7 | 28 | Citations (PDF) |
| 142 | P063 SAFETY OF BIOLOGIC THERAPY IN OLDER PATIENTS WITH IMMUNE-MEDIATED DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS | 2.3 | 1 | Citations (PDF) |
| 143 | Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis | 1.1 | 18 | Citations (PDF) |
| 144 | Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases | 30.7 | 3,040 | Citations (PDF) |
| 145 | Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases | 0.9 | 10 | Citations (PDF) |
| 146 | Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis | 5.0 | 130 | Citations (PDF) |
| 147 | Obesity and Weight Gain Since Early Adulthood Are Associated With a Lower Risk of Microscopic Colitis | 5.0 | 27 | Citations (PDF) |
| 148 | Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease | 14.4 | 176 | Citations (PDF) |
| 149 | CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis Patients | 1.5 | 5 | Citations (PDF) |
| 150 | Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study | 2.7 | 96 | Citations (PDF) |
| 151 | ACG Clinical Guideline: Ulcerative Colitis in Adults | 0.7 | 1,494 | Citations (PDF) |
| 152 | Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study | 2.3 | 13 | Citations (PDF) |
| 153 | Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis | 5.0 | 98 | Citations (PDF) |
| 154 | Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis | 1.5 | 49 | Citations (PDF) |
| 155 | Cancer risk in microscopic colitis: a retrospective cohort study | 1.7 | 52 | Citations (PDF) |
| 156 | The Gut Microbiome and Digestive Health – A New Frontier | 5.0 | 9 | Citations (PDF) |
| 157 | Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases | 5.0 | 12 | Citations (PDF) |
| 158 | Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence | 1.5 | 23 | Citations (PDF) |
| 159 | Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women | 0.9 | 36 | Citations (PDF) |
| 160 | Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn’s Disease Is Not Associated with Emergence of Novel Inflammatory Pathways | 1.5 | 21 | Citations (PDF) |
| 161 | Enabling phenotypic big data with PheNorm | 3.3 | 115 | Citations (PDF) |
| 162 | Dynamics of metatranscription in the inflammatory bowel disease gut microbiome | 9.9 | 580 | Citations (PDF) |
| 163 | Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases | 0.9 | 31 | Citations (PDF) |
| 164 | Genetic Markers Predict Primary Nonresponse and Durable Response to Anti–Tumor Necrosis Factor Therapy in Ulcerative Colitis | 2.3 | 49 | Citations (PDF) |
| 165 | Depression but Not Symptom Severity is Associated With Work and School Absenteeism in Refractory Chronic Constipation | 1.6 | 12 | Citations (PDF) |
| 166 | Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India | 1.8 | 19 | Citations (PDF) |
| 167 | Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies | 5.0 | 121 | Citations (PDF) |
| 168 | Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines | 5.0 | 124 | Citations (PDF) |
| 169 | “Weekend Effect” in Patients With Upper Gastrointestinal Hemorrhage: A Systematic Review and Meta-analysis | 0.7 | 44 | Citations (PDF) |
| 170 | Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis—Results From the Nurses’ Health Study | 0.9 | 38 | Citations (PDF) |
| 171 | Bugs and drugs: Predicting response to therapy | 1.8 | 0 | Citations (PDF) |
| 172 | The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children | 0.7 | 44 | Citations (PDF) |
| 173 | Making sense of clinical predictors | 1.8 | 0 | Citations (PDF) |
| 174 | Debate session: So what causes inflammatory bowel disease? It's all in the environment | 1.8 | 6 | Citations (PDF) |
| 175 | The role of diet in the aetiopathogenesis of inflammatory bowel disease | 33.1 | 266 | Citations (PDF) |
| 176 | Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease | 2.3 | 26 | Citations (PDF) |
| 177 | IRGMGene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn’s Disease | 2.3 | 22 | Citations (PDF) |
| 178 | Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis? | 1.5 | 13 | Citations (PDF) |
| 179 | The Association Between Arthralgia and Vedolizumab Using Natural Language Processing | 2.3 | 32 | Citations (PDF) |
| 180 | Reply | 5.0 | 0 | Citations (PDF) |
| 181 | Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease | 2.3 | 40 | Citations (PDF) |
| 182 | Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis | 1.5 | 11 | Citations (PDF) |
| 183 | Reply to ‘Comment on Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients’ | 0.9 | 35 | Citations (PDF) |
| 184 | Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients | 0.9 | 36 | Citations (PDF) |
| 185 | Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort | 2.7 | 44 | Citations (PDF) |
| 186 | A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers | 10.8 | 241 | Citations (PDF) |
| 187 | Fatigue in IBD: epidemiology, pathophysiology and management | 33.1 | 241 | Citations (PDF) |
| 188 | Non-Steroidal Anti-Inflammatory Drugs and Aspirin, but Not Acetaminophen, Are Associated With an Increased Risk of Microscopic Colitis: Results From the Nurses’ Health Studies | 0.7 | 1 | Citations (PDF) |
| 189 | Nutritional Adequacy of Popular Defined Diets for Inflammatory Bowel Disease | 0.7 | 0 | Citations (PDF) |
| 190 | The impact of co‐existing immune‐mediated diseases on phenotype and outcomes in inflammatory bowel diseases | 2.7 | 41 | Citations (PDF) |
| 191 | Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis | 15.0 | 204 | Citations (PDF) |
| 192 | Genetic risk factors for serious infections in inflammatory bowel diseases | 1.1 | 8 | Citations (PDF) |
| 193 | Modifiable Environmental Factors in Inflammatory Bowel Disease | 2.2 | 31 | Citations (PDF) |
| 194 | Management of Inflammatory Bowel Disease in the Elderly Patient | 2.3 | 105 | Citations (PDF) |
| 195 | Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset | 2.3 | 22 | Citations (PDF) |
| 196 | Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases | 12.2 | 449 | Citations (PDF) |
| 197 | The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease | 2.7 | 17 | Citations (PDF) |
| 198 | Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease | 2.3 | 35 | Citations (PDF) |
| 199 | Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases | 2.3 | 24 | Citations (PDF) |
| 200 | Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease | 2.3 | 42 | Citations (PDF) |
| 201 | Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohnʼs Disease and Ulcerative Colitis | 2.3 | 49 | Citations (PDF) |
| 202 | Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials | 2.7 | 282 | Citations (PDF) |
| 203 | Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab | 1.5 | 68 | Citations (PDF) |
| 204 | Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3 | 2.3 | 38 | Citations (PDF) |
| 205 | Systematic review with meta‐analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis | 2.7 | 240 | Citations (PDF) |
| 206 | Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary N3:N6 Intake and Risk of Ulcerative Colitis | 0.9 | 1 | Citations (PDF) |
| 207 | Issue Highlights | 5.0 | 0 | Citations (PDF) |
| 208 | Surrogate-assisted feature extraction for high-throughput phenotyping | 3.3 | 80 | Citations (PDF) |
| 209 | Pivot to Asia: inflammatory bowel disease burden | 2.3 | 96 | Citations (PDF) |
| 210 | The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact | 1.5 | 109 | Citations (PDF) |
| 211 | Environmental triggers in IBD: a review of progress and evidence | 33.1 | 902 | Citations (PDF) |
| 212 | A Case Study of the Incremental Utility for Disease Identification of Natural Language Processing in Electronic Medical Records | 2.4 | 8 | Citations (PDF) |
| 213 | Does Obesity Influence the Risk of C. difficile Infection Among Patients with Ulcerative Colitis? | 0.7 | 0 | Citations (PDF) |
| 214 | Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn’s Disease and Ulcerative Colitis | 3.3 | 50 | Citations (PDF) |
| 215 | Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)—Promoting Improvement of Inflammatory Bowel Disease Education in the United States | 2.3 | 3 | Citations (PDF) |
| 216 | Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease Cohort | 2.3 | 19 | Citations (PDF) |
| 217 | Environmental Hygiene and Risk of Inflammatory Bowel Diseases | 2.3 | 92 | Citations (PDF) |
| 218 | Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis | 0.9 | 147 | Citations (PDF) |
| 219 | Tu1993 Sexual Dysfunction in Women With Inflammatory Bowel Disease: A New IBD-Specific Scale | 0.9 | 10 | Citations (PDF) |
| 220 | Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes | 1.5 | 19 | Citations (PDF) |
| 221 | P-014 Circulating C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease | 2.3 | 0 | Citations (PDF) |
| 222 | Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States | 1.9 | 18 | Citations (PDF) |
| 223 | Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn’s Disease | 0.7 | 92 | Citations (PDF) |
| 224 | A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition | 0.9 | 146 | Citations (PDF) |
| 225 | Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis | 5.0 | 14 | Citations (PDF) |
| 226 | A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis | 10.8 | 57 | Citations (PDF) |
| 227 | State of Adult Trainee Inflammatory Bowel Disease Education in the United States | 2.3 | 29 | Citations (PDF) |
| 228 | Comparative Effectiveness of Infliximab and Adalimumab in Crohnʼs Disease and Ulcerative Colitis | 2.3 | 52 | Citations (PDF) |
| 229 | Toward reducing bias in clinical trials: central readers for endoscopic endpoints | 1.0 | 4 | Citations (PDF) |
| 230 | Chromoendoscopy Is Better: So Why Am I Not (yet) Using it for Routine Inflammatory Bowel Disease Surveillance? | 5.0 | 11 | Citations (PDF) |
| 231 | Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease | 5.0 | 81 | Citations (PDF) |
| 232 | Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases | 5.0 | 77 | Citations (PDF) |
| 233 | Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease | 0.9 | 158 | Citations (PDF) |
| 234 | Computer-assisted expert case definition in electronic health records | 2.6 | 34 | Citations (PDF) |
| 235 | Diagnostic and Therapeutic Yield of Endoscopy in Patients with Elevated INR and Gastrointestinal Bleeding | 1.4 | 13 | Citations (PDF) |
| 236 | Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents | 5.0 | 112 | Citations (PDF) |
| 237 | Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases | 1.5 | 65 | Citations (PDF) |
| 238 | Influence of Age and Gender on Assessment of IBD Quality Measures in Patients with Ulcerative Colitis | 0.7 | 0 | Citations (PDF) |
| 239 | High School Diet and Risk of Crohnʼs Disease and Ulcerative Colitis | 2.3 | 92 | Citations (PDF) |
| 240 | Development of phenotype algorithms using electronic medical records and incorporating natural language processing | 0.2 | 269 | Citations (PDF) |
| 241 | Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohnʼs Disease | 2.3 | 58 | Citations (PDF) |
| 242 | Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel Diseases | 2.3 | 33 | Citations (PDF) |
| 243 | Endogenous Levels of Circulating Androgens and Risk of Crohnʼs Disease and Ulcerative Colitis Among Women | 2.3 | 19 | Citations (PDF) |
| 244 | Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study | 2.8 | 109 | Citations (PDF) |
| 245 | Reply | 5.0 | 0 | Citations (PDF) |
| 246 | Colonoscopy Is Associated With a Reduced Risk for Colon Cancer and Mortality in Patients With Inflammatory Bowel Diseases | 5.0 | 120 | Citations (PDF) |
| 247 | Epidemiology and risk factors for IBD | 33.1 | 1,625 | Citations (PDF) |
| 248 | High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease | 1.5 | 57 | Citations (PDF) |
| 249 | Rectosigmoid Localization of Radiopaque Markers Does Not Correlate with Prolonged Balloon Expulsion in Chronic Constipation: Results from a Multicenter Cohort | 0.7 | 33 | Citations (PDF) |
| 250 | Reply | 5.0 | 0 | Citations (PDF) |
| 251 | Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States | 5.0 | 53 | Citations (PDF) |
| 252 | Measures of Obesity and Risk of Crohnʼs Disease and Ulcerative Colitis | 2.3 | 163 | Citations (PDF) |
| 253 | Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts | 1.5 | 93 | Citations (PDF) |
| 254 | The Cost-Effectiveness of Competing Strategies for Managing Multiply Recurrent Clostridium difficile Infection: Examining the Impact of Universal Stool Banks and Encapsulated Fecal Microbiota Transplantation | 0.7 | 1 | Citations (PDF) |
| 255 | Correlations Between Clinical Activity Indices or Quality of Life Scores to Endoscopic Activity Scores Do not Vary According to Age at Diagnosis, Disease Location, and Disease Behavior in Inflammatory Bowel Disease | 0.7 | 0 | Citations (PDF) |
| 256 | Restricted Eating Patterns in Chronic Constipation Are Associated With Bloating and Abdominal Symptoms More so Than Rectal and Stool Symptoms | 0.7 | 0 | Citations (PDF) |
| 257 | Comorbid Depression, Not Symptom Severity or Disease-Specific Quality of Life, Predicts Work Absenteeism in Chronic Constipation | 0.7 | 0 | Citations (PDF) |
| 258 | Elevated C-Reactive Protein is Associated With Poor Sleep Quality in Patients With Inflammatory Bowel Disease | 0.7 | 0 | Citations (PDF) |
| 259 | Early life environment and natural history of inflammatory bowel diseases | 1.7 | 35 | Citations (PDF) |
| 260 | Pretreatment 25‐Hydroxyvitamin D Levels and Durability of Anti–Tumor Necrosis Factor–α Therapy in Inflammatory Bowel Diseases | 2.1 | 108 | Citations (PDF) |
| 261 | Evaluation of matched control algorithms in EHR-based phenotyping studies: A case study of inflammatory bowel disease comorbidities | 3.0 | 29 | Citations (PDF) |
| 262 | Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case–control study | 1.7 | 19 | Citations (PDF) |
| 263 | Impact of Mode of Delivery on Outcomes in Patients with Perianal Crohnʼs Disease | 2.3 | 44 | Citations (PDF) |
| 264 | Venous Thromboembolism in Patients with Inflammatory Bowel Diseases | 2.3 | 62 | Citations (PDF) |
| 265 | Natural History of Crohnʼs Disease Following Total Colectomy and End Ileostomy | 2.3 | 38 | Citations (PDF) |
| 266 | Genetic Polymorphisms in Metabolizing Enzymes Modifying the Association Between Smoking and Inflammatory Bowel Diseases | 2.3 | 40 | Citations (PDF) |
| 267 | Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases | 5.0 | 72 | Citations (PDF) |
| 268 | Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease | 0.9 | 54 | Citations (PDF) |
| 269 | Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis | 3.7 | 141 | Citations (PDF) |
| 270 | Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases | 5.0 | 110 | Citations (PDF) |
| 271 | Differential Effect of Genetic Burden on Disease Phenotypes in Crohn's Disease and Ulcerative Colitis: Analysis of a North American Cohort | 0.7 | 83 | Citations (PDF) |
| 272 | Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease | 10.3 | 482 | Citations (PDF) |
| 273 | Case 25-2014 | 26.4 | 74 | Citations (PDF) |
| 274 | Sleep Duration Affects Risk for Ulcerative Colitis: A Prospective Cohort Study | 5.0 | 111 | Citations (PDF) |
| 275 | Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases | 5.0 | 44 | Citations (PDF) |
| 276 | Reply | 5.0 | 0 | Citations (PDF) |
| 277 | Reply | 0.9 | 0 | Citations (PDF) |
| 278 | SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease | 0.9 | 52 | Citations (PDF) |
| 279 | Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis | 1.0 | 73 | Citations (PDF) |
| 280 | Mode of Childbirth and Long-Term Outcomes in Women with Inflammatory Bowel Diseases | 1.5 | 28 | Citations (PDF) |
| 281 | Environmental Risk Factors for Inflammatory Bowel Diseases: A Review | 1.5 | 173 | Citations (PDF) |
| 282 | The exposome in inflammatory bowel disease | 0.2 | 14 | Citations (PDF) |
| 283 | Early Life Environment and Natural History of Inflammatory Bowel Diseases | 0.7 | 0 | Citations (PDF) |
| 284 | Mode of Childbirth and Long-term Outcomes in Women With Inflammatory Bowel Diseases: ACG Governors Award for Excellence in Clinical Research | 0.7 | 0 | Citations (PDF) |
| 285 | Low Serum Vitamin D is Associated With Increased Risk of Community-Acquired Clostridium difficile Infection | 0.7 | 0 | Citations (PDF) |
| 286 | Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohnʼs Disease? A Decision Analysis | 2.3 | 45 | Citations (PDF) |
| 287 | Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease | 2.3 | 151 | Citations (PDF) |
| 288 | Treatment of Intra-Abdominal Abscesses in Crohn’s Disease: A Nationwide Analysis of Patterns and Outcomes of Care | 1.5 | 27 | Citations (PDF) |
| 289 | Oral contraceptives, reproductive factors and risk of inflammatory bowel disease | 10.3 | 201 | Citations (PDF) |
| 290 | Interobserver Agreement for the Detection of Barrett’s Esophagus with Optical Frequency Domain Imaging | 1.5 | 48 | Citations (PDF) |
| 291 | Dyssynergic Defecation: A Treatable Cause of Persistent Symptoms When Inflammatory Bowel Disease Is in Remission | 1.5 | 41 | Citations (PDF) |
| 292 | A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis | 0.9 | 606 | Citations (PDF) |
| 293 | Personalizing therapy for inflammatory bowel diseases | 1.6 | 11 | Citations (PDF) |
| 294 | Sleep Disturbance and Risk of Active Disease in Patients With Crohn's Disease and Ulcerative Colitis | 5.0 | 244 | Citations (PDF) |
| 295 | Association Between Depressive Symptoms and Incidence of Crohn's Disease and Ulcerative Colitis: Results From the Nurses' Health Study | 5.0 | 147 | Citations (PDF) |
| 296 | Antibiotic exposure is associated with development of inflammatory bowel disease | 1.6 | 1 | Citations (PDF) |
| 297 | Impact of Coexistent Celiac Disease on Phenotype and Natural History of Inflammatory Bowel Diseases | 0.7 | 53 | Citations (PDF) |
| 298 | Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections | 0.7 | 1,535 | Citations (PDF) |
| 299 | Similar Risk of Depression and Anxiety Following Surgery or Hospitalization for Crohn's Disease and Ulcerative Colitis | 0.7 | 83 | Citations (PDF) |
| 300 | Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases | 0.9 | 176 | Citations (PDF) |
| 301 | Improving Case Definition of Crohnʼs Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing | 2.3 | 163 | Citations (PDF) |
| 302 | Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts | 0.2 | 136 | Citations (PDF) |
| 303 | Normalization of Plasma 25-Hydroxy Vitamin D Is Associated with Reduced Risk of Surgery in Crohn’s Disease | 2.3 | 179 | Citations (PDF) |
| 304 | P-043 The Risk of Ectopic Pregnancy in Patients with Inflammatory Bowel Disease—A Retrospective Case Control Study | 2.3 | 0 | Citations (PDF) |
| 305 | Early Life Factors and Risk of Inflammatory Bowel Disease in Adulthood | 2.3 | 55 | Citations (PDF) |
| 306 | P-056 Aryl Hydrocarbon Receptor Expression—A Comparison Between Patients with IBD and Healthy Controls, and Association with Serum Fatty Acids | 2.3 | 0 | Citations (PDF) |
| 307 | How Does Genotype Influence Disease Phenotype in Inflammatory Bowel Disease? | 2.3 | 14 | Citations (PDF) |
| 308 | Does Parental Age Influence the Risk of Inflammatory Bowel Disease in Offspring? | 0.7 | 1 | Citations (PDF) |
| 309 | Cost-effectiveness of Competing Strategies for Recurrent Clostridium difficile Infection: ACG/AstraZeneca Fellow Award | 0.7 | 2 | Citations (PDF) |
| 310 | Natural History of Crohnʼs Disease Following Permanent Ileostomy: Implications for Endoscopic Surveillance | 0.7 | 0 | Citations (PDF) |
| 311 | Preventability of Venous Thromboembolism in Patients with Inflammatory Bowel Disease | 0.7 | 0 | Citations (PDF) |
| 312 | Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis | 7.3 | 247 | Citations (PDF) |
| 313 | Impact of pregnancy on health‐related quality of life of patients with inflammatory bowel disease | 1.0 | 10 | Citations (PDF) |
| 314 | Geographical variation and incidence of inflammatory bowel disease among US women | 10.3 | 199 | Citations (PDF) |
| 315 | Aspirin Protects Against Barrett's Esophagus in a Multivariate Logistic Regression Analysis | 5.0 | 59 | Citations (PDF) |
| 316 | Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation | 5.0 | 56 | Citations (PDF) |
| 317 | Detecting and Treating Clostridium Difficile Infections in Patients with Inflammatory Bowel Disease | 1.6 | 34 | Citations (PDF) |
| 318 | Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms - pediatric versus adult? | 1.7 | 91 | Citations (PDF) |
| 319 | Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease | 30.7 | 4,662 | Citations (PDF) |
| 320 | Higher Predicted Vitamin D Status Is Associated With Reduced Risk of Crohn's Disease | 0.9 | 412 | Citations (PDF) |
| 321 | Hormone Therapy Increases Risk of Ulcerative Colitis but not Crohn's Disease | 0.9 | 129 | Citations (PDF) |
| 322 | Reply to Dr. McNabb-Baltar's letter | 0.9 | 0 | Citations (PDF) |
| 323 | 863 Higher Dietary Fiber Intake is Associated With Lower Risk of Crohn's Disease but Not Ulcerative Colitis - a Prospective Study | 0.9 | 4 | Citations (PDF) |
| 324 | Vitamin D and IBD: More Pieces to the Puzzle, Still No Complete Picture | 2.3 | 5 | Citations (PDF) |
| 325 | Environmental Triggers for Inflammatory Bowel Disease | 2.2 | 100 | Citations (PDF) |
| 326 | Strategies for the Prevention of Postoperative Recurrence in Crohn's Disease: Results of a Decision Analysis | 0.7 | 46 | Citations (PDF) |
| 327 | Missed polyps, missed opportunities | 1.0 | 2 | Citations (PDF) |
| 328 | A Prospective Study of Vitamin D Status and Risk of Incident Crohn's Disease and Ulcerative Colitis | 0.9 | 1 | Citations (PDF) |
| 329 | Geographic variation and the incidence of inflammatory bowel disease among U.S. women | 2.3 | 0 | Citations (PDF) |
| 330 | Deep Vein Thrombosis and Pulmonary Embolism in Hospitalized Patients with Cirrhosis: A Nationwide Analysis | 1.5 | 74 | Citations (PDF) |
| 331 | QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States | 2.3 | 67 | Citations (PDF) |
| 332 | Physician density and hospitalization for inflammatory bowel disease | 2.3 | 10 | Citations (PDF) |
| 333 | Ambient air pollution correlates with hospitalizations for inflammatory bowel disease | 2.3 | 163 | Citations (PDF) |
| 334 | Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease | 2.3 | 143 | Citations (PDF) |
| 335 | Certolizumab Pegol Compared to Natalizumab in Patients with Moderate to Severe Crohn’s Disease: Results of a Decision Analysis | 1.5 | 18 | Citations (PDF) |
| 336 | Geographic Variations and Risk of Crohnʼs Disease and Ulcerative Colitis: Results from Two Large Prospective Cohorts: ACG IBD Award | 0.7 | 0 | Citations (PDF) |
| 337 | A Prospective Study of Aspirin, Non-steroidal Anti-inflammatory Drug Use and Risk of Crohnʼs Disease and Ulcerative Colitis: ACG Governors Award for Excellence in Clinical Research | 0.7 | 0 | Citations (PDF) |
| 338 | Impact of Autonomic Dysfunction on Inflammatory Bowel Disease | 1.6 | 29 | Citations (PDF) |
| 339 | Higher Physician Density is Associated with Lower Incidence of Late-stage Colorectal Cancer | 1.5 | 71 | Citations (PDF) |
| 340 | A Noninvasive Clinical Scoring Model Predicts Risk of Nonalcoholic Steatohepatitis in Morbidly Obese Patients | 1.5 | 57 | Citations (PDF) |
| 341 | Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? | 2.3 | 30 | Citations (PDF) |
| 342 | Clostridium difficile and inflammatory bowel disease | 2.3 | 5 | Citations (PDF) |
| 343 | Simple score to identify colectomy risk in ulcerative colitis hospitalizations | 2.3 | 37 | Citations (PDF) |
| 344 | Trends in Ambulatory and Emergency Room Visits for Inflammatory Bowel Diseases in the United States: 1994–2005 | 0.7 | 50 | Citations (PDF) |
| 345 | A Novel Risk Score to Stratify Severity of Crohn's Disease Hospitalizations | 0.7 | 60 | Citations (PDF) |
| 346 | Length of Office Visits for Gastrointestinal Disease: Impact of Physician Specialty | 0.7 | 8 | Citations (PDF) |
| 347 | Improved Efficacy of Biological Maintenance Therapy in “Early” Compared With “Late” Crohn's Disease: Strike While the Iron Is Hot With Anti-TNF Agents? | 0.7 | 9 | Citations (PDF) |
| 348 | Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective | 0.7 | 159 | Citations (PDF) |
| 349 | Clostridium Difficile and Inflammatory Bowel Disease | 2.2 | 42 | Citations (PDF) |
| 350 | Imatinib and
Panax Ginseng
: A Potential Interaction Resulting in Liver Toxicity | 1.5 | 117 | Citations (PDF) |
| 351 | Impact ofClostridium difficileon inflammatory bowel disease | 1.6 | 31 | Citations (PDF) |
| 352 | Clostridium difficile infection: epidemiology, risk factors and management | 33.1 | 336 | Citations (PDF) |
| 353 | Fracture-Associated Hospitalizations in Patients with Inflammatory Bowel Disease | 1.5 | 20 | Citations (PDF) |
| 354 | A Nationwide Analysis of Changes in Severity and Outcomes of Inflammatory Bowel Disease Hospitalizations | 1.2 | 62 | Citations (PDF) |
| 355 | Influence of Body Mass Index on Quality of Life and Disease Activity in Crohnʼs Patients: 2010 ACG/Centocor IBD Abstract Award | 0.7 | 0 | Citations (PDF) |
| 356 | Inflammatory bowel disease in the elderly is associated with worse outcomes: A national study of hospitalizations | 2.3 | 187 | Citations (PDF) |
| 357 | History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis | 2.3 | 72 | Citations (PDF) |
| 358 | Durability of infliximab in Crohnʼs disease | 2.3 | 16 | Citations (PDF) |
| 359 | Higher hospital volume predicts endoscopy but not the in-hospital mortality rate in patients with acute variceal hemorrhage | 1.0 | 10 | Citations (PDF) |
| 360 | Higher hospital volume is associated with lower mortality in acute nonvariceal upper-GI hemorrhage | 1.0 | 26 | Citations (PDF) |
| 361 | S1145 Long-Term Impact of Clostridium difficile On Inflammatory Bowel Disease | 0.9 | 8 | Citations (PDF) |
| 362 | Outcomes of Weekend Admissions for Upper Gastrointestinal Hemorrhage: A Nationwide Analysis | 5.0 | 164 | Citations (PDF) |
| 363 | Reply | 5.0 | 1 | Citations (PDF) |
| 364 | Clostridium Difficile and Inflammatory Bowel Disease | 1.6 | 61 | Citations (PDF) |
| 365 | Laparoscopic Resection for Inflammatory Bowel Disease: Outcomes from a Nationwide Sample | 1.2 | 21 | Citations (PDF) |
| 366 | Pre-operative Small Bowel Follow Through Detects more Crohnʼs Disease Strictures than CT Enterography in Patients with Multiple Strictures: Comparison with Intra-operative Findings | 0.7 | 0 | Citations (PDF) |
| 367 | Effect of Hospital Volume and Teaching Status on Outcomes of Acute Liver Failure | 1.6 | 28 | Citations (PDF) |
| 368 | Clostridium difficile and inflammatory bowel disease | 2.3 | 209 | Citations (PDF) |
| 369 | Does It Matter Where You Are Hospitalized for Inflammatory Bowel Disease? A Nationwide Analysis of Hospital Volume | 0.7 | 121 | Citations (PDF) |
| 370 | Deleterious Effect of Cirrhosis on Outcomes After Motor Vehicle Crashes Using the Nationwide Inpatient Sample | 0.7 | 34 | Citations (PDF) |
| 371 | Permanent Work Disability in Crohn's Disease | 0.7 | 92 | Citations (PDF) |
| 372 | Racial Differences in Liver Transplantation Outcomes in the MELD Era | 0.7 | 79 | Citations (PDF) |
| 373 | Impact of Anti-TNF-α Treatment Failure Complicating Long-Term Maintenance Therapy for Crohnʼs Disease | 0.7 | 0 | Citations (PDF) |
| 374 | Perception and Reality | 0.7 | 0 | Citations (PDF) |
| 375 | Vitamin D Deficiency in Inflammatory Bowel Disease Patients | 0.7 | 0 | Citations (PDF) |
| 376 | Use of a Blood IFN-γ Release Assay (Quantiferon-Tb Gold Test) for Tuberculosis Screening in Inflammatory Bowel Disease (IBD) | 0.7 | 0 | Citations (PDF) |
| 377 | Severe Pulmonary Toxicity After Azathioprine/6-Mercaptopurine Initiation for the Treatment of Inflammatory Bowel Disease | 1.6 | 55 | Citations (PDF) |
| 378 | Disparities in Colon Cancer Screening in the Medicare Population | 8.1 | 123 | Citations (PDF) |
| 379 | Caroli’s disease: Identification and treatment strategy | 2.2 | 57 | Citations (PDF) |
| 380 | Epidemiology of Primary and Secondary Liver Cancers | 0.6 | 186 | Citations (PDF) |
| 381 | The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response | 1.0 | 134 | Citations (PDF) |
| 382 | Dietary Nut and Legume Intake and Risk of Crohn’s Disease and Ulcerative Colitis | 2.3 | 3 | Citations (PDF) |
| 383 | Delayed Remission With Advanced Therapies Is Not Associated With Worse 1-Year Outcomes in Inflammatory Bowel Disease | 0.7 | 0 | Citations (PDF) |
| 384 | Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases | 2.7 | 3 | Citations (PDF) |
| 385 | Cross-Sectional Imaging Features Associated With Disease Progression in Crohn’s Disease | 2.3 | 2 | Citations (PDF) |
| 386 | Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study | 2.4 | 2 | Citations (PDF) |
| 387 | AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease | 0.9 | 27 | Citations (PDF) |
| 388 | Women and Younger Adults With Inflammatory Bowel Disease are at Greater Risk of Financial Toxicity From Inflammatory Bowel Disease | 0.7 | 0 | Citations (PDF) |
| 389 | Phenotypic Differences in Inflammatory Bowel Diseases Across Race, Ethnicity, and Geography: A Systematic Review of 237 Population-Based Studies | 5.0 | 0 | Citations (PDF) |
| 390 | Dairy Intake and Risk of Incident Inflammatory Bowel Disease in US Men and Women | 1.7 | 0 | Citations (PDF) |
| 391 | Frailty in inflammatory bowel disease: a missing link in personalized care for the aging IBD population | 2.3 | 0 | Citations (PDF) |
| 392 | Differences in Outcomes After Ileocecal Resection in Older Adults With Crohn's Disease in the Biologic Era | 0.7 | 0 | Citations (PDF) |
| 393 | Disease reprogression following surgical resection in Crohn disease | 2.3 | 0 | Citations (PDF) |
| 394 | Advanced therapies for extraintestinal manifestations of IBD: a systematic review and meta-analysis | 2.3 | 0 | Citations (PDF) |
| 395 | Tu1557 COMPARATIVE SAFETY OF LONG-TERM BUDESONIDE VERSUS SYSTEMIC STEROIDS IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES OR MICROSCOPIC COLITIS | 1.0 | 0 | Citations (PDF) |
| 396 | Tu1588 COMPARATIVE RISK OF CANCER WITH IL-12/23 OR IL-23 INHIBITORS AND ANTI-TNFS IN INFLAMMATORY BOWEL DISEASES | 1.0 | 0 | Citations (PDF) |
| 397 | 323 IMPACT OF BASELINE PHYSICAL ACTIVITY ON RISK OF DISEASE FLARES, QUALITY OF LIFE, AND GUT MICROBIOME IN INFLAMMATORY BOWEL DISEASES: A PROSPECTIVE COHORT STUDY | 1.0 | 0 | Citations (PDF) |
| 398 | 1175 MULTI-BACTERIA BIOMARKER PANEL FOR INFLAMMATORY BOWEL DISEASE DIAGNOSIS - AN INTERNATIONAL MULTI-CENTER STUDY | 1.0 | 0 | Citations (PDF) |
| 399 | Tu1495 MACHINE-LEARNING BASED STRATIFICATION IDENTIFIES TREATMENT TRAJECTORY SUBTYPES AND UNMET NEED IN INFLAMMATORY BOWEL DISEASES | 1.0 | 0 | Citations (PDF) |
| 400 | Mo1554 COMPARATIVE EFFECTIVENESS OF ADVANCED THERAPIES FOR PREVENTING PENETRATING COMPLICATIONS IN CROHN’S DISEASE: AN ADMINISTRATIVE CLAIMS-BASED STUDY | 1.0 | 0 | Citations (PDF) |
| 401 | Sa1569 INCIDENCE AND PREVALENCE OF COMMON GYNECOLOGIC CONDITIONS IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: ENDOMETRIOSIS AND FIBROIDS | 1.0 | 0 | Citations (PDF) |
| 402 | 703 THE IMPACT OF NORMALIZATION OF HISTOLOGY ON DISEASE COURSE IN MICROSCOPIC COLITIS: A RETROSPECTIVE COHORT STUDY | 1.0 | 0 | Citations (PDF) |
| 403 | Sa1500 MIRIKIZUMAB TREATMENT DECREASES ULCERATIVE COLITIS-RELATED SURGERY AND HOSPITALIZATION RATES: 4-YEAR LUCENT STUDIES RESULTS | 1.0 | 0 | Citations (PDF) |
| 404 | Sa1599 IMPROVEMENTS IN WORK PRODUCTIVITY OVER TIME IN PATIENTS WITH IBD-ASSOCIATED PERIPHERAL SPONDYLOARTHRITIS | 1.0 | 0 | Citations (PDF) |
| 405 | 36 IMPACT OF PRIOR EXPOSURE TO ADVANCED THERAPY AND TIMING OF DISCONTINUATION ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH IBD STARTING A NEW ADVANCED THERAPY | 1.0 | 0 | Citations (PDF) |
| 406 | Tu1494 MACHINE LEARNING-BASED STRATIFICATION TO DEFINE DISTINCT DISEASE TRAJECTORIES FOLLOWING ADVANCED THERAPY INITIATION IN CROHN’S DISEASE AND ULCERATIVE COLITIS | 1.0 | 0 | Citations (PDF) |
| 407 | Tu1592 CANCER RISK ASSOCIATED WITH COMBINATION METHOTREXATE AND ANTI-TNF THERAPY VERSUS ANTI-TNF MONOTHERAPY FOR INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT STUDY. | 1.0 | 0 | Citations (PDF) |
| 408 | 538 COMPARATIVE EFFECTIVENESS OF JAK INHIBITORS VERSUS IL-23 INHIBITORS IN USTEKINUMAB FAILURES IN MODERATE-TO-SEVERE CROHN’S DISEASE | 1.0 | 0 | Citations (PDF) |
| 409 | Tu1584 CANCER RISK WITH ADVANCED THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: AN ADMINISTRATIVE CLAIMSBASED STUDY | 1.0 | 0 | Citations (PDF) |
| 410 | Sa1627 IMPACT OF ADVANCED THERAPY INITIATION ON ANTIBIOTIC DEPENDENCE IN CHRONIC POUCHITIS | 1.0 | 0 | Citations (PDF) |
| 411 | Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multistrain Probiotic Supplementation | 0.7 | 0 | Citations (PDF) |
| 412 | Impact of advanced therapy initiation on antibiotic dependence in chronic pouchitis | 2.3 | 0 | Citations (PDF) |
| 413 | The impact of normalization of histology on disease course in microscopic colitis: a retrospective cohort study | 2.3 | 0 | Citations (PDF) |
| 414 | Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD | 2.3 | 0 | Citations (PDF) |
| 415 | Polygenic Risk Scores Show Distinct Genetic Architectures of IBD-Associated Comorbidities | 1.5 | 0 | Citations (PDF) |
